# Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

> **NCT06710210** · NA · RECRUITING · sponsor: **University Hospital, Geneva** · enrollment: 150 (estimated)

## Conditions studied

- Coronary Artery Disease
- Diffuse Coronary Artery Disease
- Percutaneous Coronary Intervention (PCI)

## Interventions

- **DEVICE:** PCI with a bioresorbable scaffold and drug-coated balloon(s)
- **DEVICE:** PCI with drug-eluting stent(s)

## Key facts

- **NCT ID:** NCT06710210
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710210, "Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06710210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*